Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Marimed (MRMD) Operating Expenses (2016 - 2025)

Marimed (MRMD) has disclosed Operating Expenses for 15 consecutive years, with $15.0 million as the latest value for Q4 2025.

  • Quarterly Operating Expenses rose 6.39% to $15.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $60.7 million through Dec 2025, up 1.18% year-over-year, with the annual reading at $60.7 million for FY2025, 1.16% up from the prior year.
  • Operating Expenses for Q4 2025 was $15.0 million at Marimed, up from $14.8 million in the prior quarter.
  • The five-year high for Operating Expenses was $16.0 million in Q1 2025, with the low at $6.1 million in Q1 2021.
  • Average Operating Expenses over 5 years is $12.8 million, with a median of $13.8 million recorded in 2023.
  • The sharpest move saw Operating Expenses soared 299.08% in 2021, then decreased 10.95% in 2022.
  • Over 5 years, Operating Expenses stood at $14.3 million in 2021, then dropped by 10.95% to $12.7 million in 2022, then rose by 17.16% to $14.9 million in 2023, then decreased by 5.25% to $14.1 million in 2024, then rose by 6.39% to $15.0 million in 2025.
  • According to Business Quant data, Operating Expenses over the past three periods came in at $15.0 million, $14.8 million, and $14.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.